Revvity | Fremdkapital

Aktienkurs
98.31
Täglich Wechseln
-0.70 -0.71%
Monatlich
-11.54%
Jährlich
-12.34%
Q1 Prognose
97.22




Fremdkapital Veränderung Datum
Agilent USD 3.05B 0 2025-12
Align Technology USD 0 0 2024-12
Bio Techne USD 260M 40M 2025-12
Bio-Rad Laboratories USD 1.2B 300K 2025-12
Bruker USD 1.85B 131.7M 2025-12
Celltrion KRW 63.29B 4.01B 2025-09
Charles River Laboratories USD 2.14B 49.09M 2025-12
Cspc Pharmaceutical CNY 158.75M 102.62M 2025-06
Danaher USD 18.42B 1.58B 2025-12
Dentsply International USD 2.02B 2M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
Edwards Lifesciences USD 598.2M 200K 2025-09
Exact Sciences USD 2.33B 9.34M 2025-09
Hologic USD 2.5B 2.1M 2025-12
Illumina USD 1.49B 496M 2025-12
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 13.88B 1.09B 2025-12
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Laboratory Of America USD 5.15B 800K 2025-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.67M 95K 2025-06
Mesa Laboratories USD 104.2M 104.3M 2024-09
Mettler Toledo International USD 2.09B 58.01M 2025-12
Myriad Genetics USD 119.5M 60.2M 2025-09
OraSure Technologies USD 0 0 2024-09
Organigram Holdings CAD 76.4M 23.6M 2025-09
Ovoca Bio EUR 0 0 2021-06
Pacific Biosciences Of California USD 893.14M 300K 2024-09
Pharma Mar EUR 37.75M 180K 2025-09
Qiagen NV USD 1.65B 15.23M 2025-12
Quest Diagnostics USD 5.17B 4M 2025-12
Quidel USD 2.47B 2.47B 2025-12
Repligen USD 542.21M 4.29M 2025-12
Revvity USD 2.63B 543K 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Thermo Fisher Scientific USD 35.85B 4B 2025-12
Tilray USD 279.22M 18.87M 2025-03
Waters USD 1.41B 460.24M 2025-12
Zz Pientze Pharmaceu CNY 186.56M 9.75M 2025-09


Revvity Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.